|Articles|January 4, 2023
Clinscience Joins Forces With OncoBay Clinical
Transaction gives NEUCA Group a 72.6% stake in OncoBay.
Advertisement
Neuca Clinical Trials Inc, a holding company held by Neuca Group, the proprietor of Clinscience international CRO has joined forces with Florida-based oncological CRO, OncoBay Clinical.
The transaction gives NEUCA Group a 72.6% stake in OncoBay. Based in Tampa, Florida, the CRO was founded by Moffit Cancer Center.
Read more about the transaction
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
SCOPE Summit 2026 Panel Discussion: Diversity in Clinical Trials—What’s Working, What’s Next
2
SCOPE Summit 2026 Keynote Panel: Is Radical Acceleration in Clinical Research Possible?
3
SCOPE Summit 2026: Elevating Patient Experience in Clinical Operations
4
SCOPE Summit 2026: Reducing Patient Burden Is the Foundation of Wearable Success in Oncology
5